AccelBio Inc is a biotechnology company based in New York, New York, specializing in advanced cell and molecular biology services. Located in the heart of Manhattan, this company provides a comprehensive range of solutions including primary and transgenic cell sourcing, high-throughput drug screening, and custom assay development tailored to neuroscience and RNA biology research. Their offerings are designed to support preclinical animal studies and innovative testing approaches related to emerging health challenges, such as Covid-19.
As a biotechnology company in New York, AccelBio Inc caters to researchers, pharmaceutical developers, and academic institutions seeking reliable biological materials and cutting-edge assay technologies. The company focuses on delivering precise and customizable services that address the complexities of drug discovery and biomedical research. By integrating specialized cell lines and tailored biochemical assays, they facilitate the evaluation of new therapeutic candidates and biological pathways.
AccelBio Inc’s expertise extends to creating innovative testing platforms that enhance the efficiency and accuracy of experimental workflows. Their commitment to advancing preclinical research models contributes to a better understanding of disease mechanisms and therapeutic responses. Located at 49 W 38th Street, their strategic position allows for close collaboration with local and regional research communities, supporting the dynamic biotechnology ecosystem in New York.
The company can be contacted by phone at 718-845-7374 for inquiries related to their biotechnology services. AccelBio Inc serves as a vital resource for scientific research and development efforts, providing essential tools and expertise needed to accelerate innovation in life sciences.


































